• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重 COVID-19 患者的巨细胞病毒肺炎。

Cytomegalovirus Pneumonia in Patients with Severe COVID-19.

机构信息

Senior Consultant, Sir Ganga Ram Hospital, Delhi, India.

DNB Student, Sir Ganga Ram Hospital, Delhi, India, Corresponding Author.

出版信息

J Assoc Physicians India. 2024 Aug;72(8):101-103. doi: 10.59556/japi.72.0489.

DOI:10.59556/japi.72.0489
PMID:39163081
Abstract

Severe pneumonia accounts for 15% of the total severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, and the affected patients require hospitalization and oxygen support. In addition, 5% of patients with severe coronavirus disease 2019 (COVID-19) experience acute respiratory distress syndrome and sepsis, which contributes to the high mortality rate. Moreover, the risk of severe COVID-19 increases with age and is the highest among elderly people over 70 years of age. Notably, these pneumonia cases can be attributed to the reactivation of latent cytomegalovirus (CMV). We hereby report two cases of patients with COVID-19 who required prolonged mechanical ventilation and were later diagnosed with secondary CMV pneumonia. These cases support the theory that in some patients with severe COVID-19, there is a possibility of CMV reactivation, contributing to the disease's severity and pathogenesis. These cases also highlight the risk involved in using steroids for a long time and the requirement of routine evaluation for CMV infection in patients with COVID-19 who require prolonged mechanical ventilation or have difficulty weaning off from the ventilator support.

摘要

严重肺炎占总严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染的 15%,受影响的患者需要住院和吸氧支持。此外,5%的严重 2019 年冠状病毒病(COVID-19)患者会出现急性呼吸窘迫综合征和败血症,这导致了高死亡率。此外,COVID-19 的严重风险随着年龄的增长而增加,在 70 岁以上的老年人中风险最高。值得注意的是,这些肺炎病例可归因于潜伏的巨细胞病毒(CMV)的再激活。我们在此报告两例 COVID-19 患者,他们需要长时间机械通气,后来被诊断为继发 CMV 肺炎。这些病例支持了这样一种理论,即在一些严重 COVID-19 患者中,CMV 再激活的可能性导致了疾病的严重程度和发病机制。这些病例还突出了长期使用类固醇的风险,以及对于需要长时间机械通气或难以从呼吸机支持中脱机的 COVID-19 患者,常规评估 CMV 感染的必要性。

相似文献

1
Cytomegalovirus Pneumonia in Patients with Severe COVID-19.严重 COVID-19 患者的巨细胞病毒肺炎。
J Assoc Physicians India. 2024 Aug;72(8):101-103. doi: 10.59556/japi.72.0489.
2
Analysis of the effect of cytomegalovirus infection in clinical outcomes and prolonged duration of SARS-CoV-2 shedding in intensive care unit patients with COVID-19 pneumonia.分析巨细胞病毒感染对 COVID-19 肺炎重症监护病房患者临床结局和 SARS-CoV-2 脱落时间延长的影响。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231209150. doi: 10.1177/17534666231209150.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.COVID-19 相关急性呼吸窘迫综合征患者中的肺单纯疱疹病毒和巨细胞病毒。
Intensive Care Med. 2024 Aug;50(8):1251-1264. doi: 10.1007/s00134-024-07529-x. Epub 2024 Jul 17.
5
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.美国 10131 名 SARS-CoV-2 感染退伍军人住院、机械通气或死亡的危险因素。
JAMA Netw Open. 2020 Sep 1;3(9):e2022310. doi: 10.1001/jamanetworkopen.2020.22310.
6
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients.低血钾症作为 COVID-19 肺炎疾病严重程度和有创机械通气需求的敏感生物标志物:306 例地中海患者的病例系列。
Int J Infect Dis. 2020 Nov;100:449-454. doi: 10.1016/j.ijid.2020.09.033. Epub 2020 Sep 17.
7
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.COVID-19 危重症患者巨细胞病毒血液再激活:危险因素及其对死亡率的影响。
Intensive Care Med. 2022 Jun;48(6):706-713. doi: 10.1007/s00134-022-06716-y. Epub 2022 May 18.
8
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征:一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
9
Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia.血红蛋白水平下降预示着 COVID-19 合并肺炎患者发生严重呼吸衰竭的风险增加。
Respir Investig. 2021 Mar;59(2):187-193. doi: 10.1016/j.resinv.2020.10.009. Epub 2020 Nov 23.
10
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.